CareDx - 11 Year Stock Price History | CDNA
- The all-time high CareDx stock closing price was 95.60 on January 20, 2021.
- The CareDx 52-week high stock price is 34.84, which is 57.3% above the current share price.
- The CareDx 52-week low stock price is 7.42, which is 66.5% below the current share price.
- The average CareDx stock price for the last 52 weeks is 20.14.
CareDx Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 22.9313 | 21.5200 | 25.0700 | 20.8900 | 22.1500 | 3.46% |
2024 | 17.9393 | 11.9400 | 33.9900 | 7.5600 | 21.4100 | 78.42% |
2023 | 9.6327 | 11.1000 | 17.6100 | 4.9000 | 12.0000 | 5.17% |
2022 | 25.6693 | 46.6000 | 46.6000 | 10.8800 | 11.4100 | -74.91% |
2021 | 71.2634 | 71.4900 | 95.6000 | 41.2000 | 45.4800 | -37.23% |
2020 | 35.7752 | 21.1500 | 77.0900 | 13.9400 | 72.4500 | 235.88% |
2019 | 27.9135 | 23.9800 | 40.0800 | 19.2400 | 21.5700 | -14.20% |
2018 | 15.5675 | 7.0500 | 30.0200 | 5.1800 | 25.1400 | 242.51% |
2017 | 2.9090 | 2.3000 | 7.3700 | 0.7857 | 7.3400 | 171.85% |
2016 | 4.4480 | 6.2700 | 6.3300 | 2.6500 | 2.7000 | -57.81% |
2015 | 6.0152 | 7.2250 | 7.6700 | 4.1100 | 6.4000 | -11.72% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.146B | $0.280B |
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $150.904B | 28.19 |
Elevance Health (ELV) | United States | $87.590B | 11.69 |
CVS Health (CVS) | United States | $79.455B | 11.63 |
Cencora (COR) | United States | $47.362B | 17.19 |
DiDi Global (DIDIY) | China | $23.670B | 0.00 |
Natera (NTRA) | United States | $20.908B | 0.00 |
ICON (ICLR) | Ireland | $16.429B | 14.61 |
Revvity (RVTY) | United States | $13.985B | 23.45 |
BioMerieux (BMXMF) | France | $13.758B | 0.00 |
Viatris (VTRS) | United States | $13.595B | 4.19 |
Doximity (DOCS) | United States | $13.537B | 70.40 |
Solventum (SOLV) | United States | $13.178B | 0.00 |
Avantor (AVTR) | United States | $11.895B | 17.47 |
CochLear (CHEOY) | Australia | $11.072B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
HealthEquity (HQY) | United States | $9.484B | 47.58 |
Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
Organon (OGN) | United States | $3.884B | 3.96 |
Sotera Health (SHC) | United States | $3.814B | 20.40 |
BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
Concentras Parent (CON) | United States | $2.951B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
PACS (PACS) | United States | $1.980B | 0.00 |
Progyny (PGNY) | United States | $1.961B | 39.71 |
Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
Premier (PINC) | United States | $1.690B | 10.82 |
Agilon Health (AGL) | United States | $1.500B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
Embecta (EMBC) | United States | $0.798B | 5.47 |
Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
SBC Medicals (SBC) | United States | $0.484B | 0.00 |
MultiPlan (MPLN) | United States | $0.472B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
DocGo (DCGO) | United States | $0.453B | 17.08 |
InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
Enhabit (EHAB) | United States | $0.406B | 35.09 |
QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
Nutex Health (NUTX) | United States | $0.314B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
LifeMD (LFMD) | United States | $0.248B | 0.00 |
Beauty Health (SKIN) | United States | $0.194B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
Biodesix (BDSX) | United States | $0.122B | 0.00 |
So-Young (SY) | China | $0.116B | 19.63 |
Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
ModivCare (MODV) | United States | $0.071B | 3.85 |
Oncology Institute (TOI) | United States | $0.064B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
KindlyMD (KDLY) | United States | $0.013B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |